Liqun Zhou
- Molecular Biology top 5%
- Surgery top 2%
- Pulmonary and Respiratory Medicine top 1%
- Cancer Research top 1%
- Oncology top 2%
- Topics
- Bladder and Urothelial Cancer Treatments (116 papers)Renal cell carcinoma treatment (80 papers)Urinary and Genital Oncology Studies (62 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaPLoS ONE
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Liqun Zhou
340 papers receiving 5.1k citations
Hit Papers
Peers
Comparison fields: 5 of 154
- Molecular Biology 1.8k
- Surgery 1.7k
- Pulmonary and Respiratory Medicine 1.6k
- Cancer Research 1.1k
- Oncology 1.1k
Countries citing papers authored by Liqun Zhou
This map shows the geographic impact of Liqun Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liqun Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liqun Zhou more than expected).
Fields of papers citing papers by Liqun Zhou
This network shows the impact of papers produced by Liqun Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liqun Zhou. The network helps show where Liqun Zhou may publish in the future.
Co-authorship network of co-authors of Liqun Zhou
This figure shows the co-authorship network connecting the top 25 collaborators of Liqun Zhou. A scholar is included among the top collaborators of Liqun Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liqun Zhou. Liqun Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 30 | |
| 5 | 1 | |
| 6 | 0 | |
| 7 | 4 | |
| 8 | 1 | |
| 9 | 23 | |
| 10 | 3 | |
| 11 | 1 | |
| 12 | 10 | |
| 13 | 14 | |
| 14 | 26 | |
| 15 | 3 | |
| 16 | 11 | |
| 17 | 1 | |
| 18 | 27 | |
| 19 | 35 | |
| 20 | Integrated Industry Is a New Trend of Evolvement of Organization Industry | 0 |
About Liqun Zhou
Liqun Zhou is a scholar working on Urology, Obstetrics and Gynecology and Pulmonary and Respiratory Medicine, having authored 364 papers that have together received 5.1k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (116 papers), Renal cell carcinoma treatment (80 papers) and Urinary and Genital Oncology Studies (62 papers). The work is most often cited by research in Urology (628 citations), Cancer Research (1.1k citations) and Obstetrics and Gynecology (422 citations). Liqun Zhou has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xuesong Li, Shiming He, Yanqing Gong, Dong Fang, Xuesong Li, Zhisong He, Gengyan Xiong, Rui Rui, Anbang He and Bao Guan. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.